UBS(Lux)E.F.-Biotech(USD)P a.SEK/ LU1991432631 /
NAV2024-05-10 | Chg.-7.3000 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
944.9900SEK | -0.77% | reinvestment | Equity | UBS Fund M. (LU) ▶ |
Funds documents
Date | Document | Year | Language | Filesize |
---|---|---|---|---|
2024-05-14 | Public WebStation Live Factsheet | 2024 | English | - |
2024-04-24 | PRIIP Key Information Document | 2024 | English | 101.80 KB |
2024-04-24 | PRIIP Key Information Document | 2024 | German | 100.08 KB |
2024-04-20 | Prospectus | 2024 | English | 2,030.67 KB |
2024-04-20 | Prospectus | 2024 | German | 2,093.54 KB |
2023-11-30 | Account statment | 2023 | English | 2,674.34 KB |
2023-11-30 | Account statment | 2023 | German | 1,415.90 KB |
2023-05-31 | Semi-annual report | 2023 | English | 1,223.68 KB |
2023-05-31 | Semi-annual report | 2023 | German | 1,239.69 KB |
2022-02-14 | Key Investor Information | 2022 | German | 54.53 KB |